Condition
Dyslipidemia
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 215 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownPolypills Approach for Multiple Cardiovascular Risk FactorsNCT07679828 · 2026-07-11
RECRUITINGA Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy VolunteersNCT07682948 · 2026-07-01
RECRUITINGKodo Millet Porridge and Its Effects on Gut Health and Metabolic SyndromeNCT07703371 · 2026-06-01
RECRUITINGDigital Care for Holistic Health in Older Adults With Diabetes and MultimorbidityNCT07310849 · 2026-05-12
RECRUITINGA Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk FactorsNCT07238556 · 2026-03-30
RECRUITINGIntermittent Cottonseed Oil ConsumptionNCT07246408 · 2026-01-16
RECRUITINGThe SWITCH (Substitution of High With Low Ultra-processed Soy Protein Foods In a Guideline-based Diet inTervention for Cardiometabolic Health) TrialNCT06907862 · 2025-08-06
RECRUITINGCardiovascular-Kidney-Metabolic Syndrome in Shanghai ZicitizensNCT07043166 · 2025-07-01
RECRUITINGTaiwan Green Propolis for Blood Lipids and Body Fat in Patients With MASLDNCT07692438 · 2025-05-28
RECRUITINGGoal Commitment and Proactive Health Behavior in Chronic Disease PatientsNCT07552571 · 2025-05-15
RECRUITINGWearable Devices Empowering Active Health Initiatives for High-Risk Stroke PopulationsNCT06935513 · 2025-04-20
RECRUITINGComparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes PatientsNCT07045623 · 2025-04-01
RECRUITINGPrescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese AdultsNCT07221279 · 2025-01-13
RECRUITINGEvaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and DyslipidemiaNCT06643130 · 2024-12-02
RECRUITINGJockey Club Precision Prevention Programme on Young Onset DiabetesNCT06693934 · 2024-11-23
RECRUITINGOsaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2NCT06694012 · 2024-11-01
RECRUITINGCottonseed Oil Versus Matched PUFA EffectsNCT06382298 · 2024-08-31
RECRUITINGClinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional StudyNCT07447362 · 2024-07-24
RECRUITINGEvaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and DyslipidemiaNCT06772168 · 2024-04-19
RECRUITINGCholine Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined DyslipidemiaNCT05365425 · 2023-06-01
RECRUITINGCardiometabolic Effects of the Recommended Daily Pecan Intake DoseNCT07696403 · 2027-03-01
NOT_YET_RECRUITINGCommunity Physical Exercise Program in Chronic DiseaseNCT06771024 · 2026-10-01
NOT_YET_RECRUITINGThe Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes MellitusNCT07476248 · 2026-10-01
NOT_YET_RECRUITINGA Retrospective Real-World Cohort StudyNCT07781371 · 2026-08-20
ACTIVE_NOT_RECRUITINGEffect of macaúba Oil Combined With Green ExercisesNCT07715461 · 2026-08-01
NOT_YET_RECRUITINGVitamin D Status and Lipid Profile in Obese Adults With Type 2 DiabetesNCT07729553 · 2026-07-25
NOT_YET_RECRUITINGReducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKDNCT07654231 · 2026-07-01
NOT_YET_RECRUITINGA Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231CNCT07590167 · 2026-06-01
NOT_YET_RECRUITINGImpact of a Produce Prescription Program and Nutrition Education Intervention on Cardiovascular Health in YouthNCT07545005 · 2026-06-01
NOT_YET_RECRUITINGLLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and DyslipidemiaNCT07350486 · 2026-05-14
ACTIVE_NOT_RECRUITINGTo Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 YearsNCT07387393 · 2026-05-01
ENROLLING_BY_INVITATIONImplementation Facilitation of Exercise is Medicine GreenvilleNCT07340580 · 2026-05-01
NOT_YET_RECRUITINGValidation of Remote Photoplethysmography (rPPG)-Derived Cardiovascular Parameters Against Standard Clinical Measurements and Risk Scores in a CommunityNCT07502703 · 2026-04-23
NOT_YET_RECRUITINGEffect of a Low-Calorie MCT-Rich Traditional Minangkabau Diet on Obese IndividualsNCT07423884 · 2026-04-01
NOT_YET_RECRUITINGDevelopment and Validation of a Comprehensive Management Service Package for Older Adults With MultimorbidityNCT07151430 · 2025-12-01
NOT_YET_RECRUITINGObservational Study for the Characterisation of Patients Affected by Any Type of Diabetes and Endocrine DisordersNCT07206875 · 2025-11-01
NOT_YET_RECRUITINGImpact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus PatientsNCT07268781 · 2025-10-20
COMPLETEDEvaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk ManagementNCT07208331 · 2025-10-06
NOT_YET_RECRUITINGEFFECTS OF A YERBA MATE EXTRACT IN REDUCING METABOLIC SYNDROME IN OVERWEIGHT INDIVIDUALSNCT07000825 · 2025-10-06
ENROLLING_BY_INVITATIONTargeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot TrialNCT07119658 · 2025-07-08
COMPLETEDImplementation and Effectiveness of "CareAide® App" for People with Cardiometabolic Diseases At a Primary Care ClinicNCT06779591 · 2025-04-30
NOT_YET_RECRUITINGImprovement and Safety of Nutrilite Protein MetX Pro on Weight Management in Overweight Individuals With DyslipidemiaNCT07094022 · 2025-03-16
COMPLETEDEffectiveness of a Mobile Health Management Program for Colorectal Cancer Survivors With Chronic ConditionsNCT06759844 · 2025-01-01
UNKNOWNSCORE! Non-Physician Health Worker (NPHW) Implementation Protocol (SIP)NCT06694987 · 2024-11-20
NOT_YET_RECRUITINGPharmacist Case Finding and Intervention for Vascular Prevention TrialNCT06405880 · 2024-11-04
ACTIVE_NOT_RECRUITINGWeight Inclusive and Adaptive Strategies to Enhance Cardiometabolic Health in Black AdultsNCT06284681 · 2024-10-01
COMPLETEDExercise Impact in Elderly With Multimorbidity: HbA1c and Blood PressureNCT06879639 · 2024-09-09
ACTIVE_NOT_RECRUITINGPeau o le Vasa: Analysis of the Efficacy and Feasibility of the PILI Lifestyle Program (PLP) + Social Determinants of Health (SDOH) Intervention and Adaptation of SDOH Measures Pilot StudyNCT06471595 · 2024-09-01
COMPLETEDAdvanced Strategy of Food Supplements for the Optimization of Satiety and Lipid Metabolism in Maturity (SACIANS)NCT07269795 · 2024-09-01
COMPLETEDEffect of Omega 3 in Hypertensive PatientsNCT06840964 · 2023-03-23
COMPLETEDChemotherapy-induced Lipid Profile Changes in Women With Early Breast CancerNCT06958783 · 2023-03-05
COMPLETEDEfficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and DyslipidemiaNCT04603508 · 2023-03-01
UNKNOWNLipid Balance in Adult Sickle Cell PatientsNCT05780775 · 2022-11-30
ACTIVE_NOT_RECRUITINGTo Evaluate the Efficacy and Safety in Patients With Dyslipidemia and HypertensionNCT05331014 · 2021-11-15
COMPLETEDEffect of Dietary Fiber on Metabolic Syndrome, Gastrointestinal Function, Mood and Sleep Quality in Obese PeopleNCT06626867 · 2021-10-01
COMPLETEDPilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in PsoriasisNCT04271735 · 2020-08-26
COMPLETEDObservational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax TabNCT05184179 · 2019-12-01
COMPLETEDTo Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With DyslipidemiaNCT04155645 · 2019-11-21
COMPLETEDFixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.NCT02662894 · 2019-10-01
WITHDRAWNComparative Outcomes of One-Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass As Revisional Procedures Following Failed Restrictive Bariatric SurgeryNCT06794892 · 2019-01-01
COMPLETEDCommon interventions
PlaceboDRUG18AtorvastatinDRUG6ControlOTHER5PitavastatinDRUG5DietOTHER4FenofibrateDRUG4metforminDRUG4PlaceboDIETARY_SUPPLEMENT4RosuvastatinDRUG4ExerciseBEHAVIORAL3PlaceboOTHER3SimvastatinDRUG3Amlodipine/AtorvastatinDRUG2Atorvastatin (Lipitor)DRUG2EzetimibeDRUG2Interactive EducationBEHAVIORAL2Laparoscopic sleeve gastrectomyPROCEDURE2Pharmacologic case managementPROCEDURE2PolicosanolDRUG2Rimonabant (SR141716)DRUG2TelmisartanDRUG2Usual CareOTHER215 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic RetinopathyOTHER1Abilify (aripiprazole)DRUG1Academic detailingOTHER1
Leading sponsors
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
7
John Sievenpiper
6
Sanofi
6
AstraZeneca
5
Solvay Pharmaceuticals
4
UCSF Benioff Children's Hospital Oakland
4
Daewoong Pharmaceutical Co. LTD.
3
EMS
3
JW Pharmaceutical
3
Providence VA Medical Center
3
University of Georgia
3
University of Hawaii
3
University of Toronto
3
Yuhan Corporation
3
Boston Children's Hospital
2
Trial status mix
COMPLETED130
UNKNOWN27
RECRUITING20
NOT_YET_RECRUITING16
TERMINATED11
ACTIVE_NOT_RECRUITING7
ENROLLING_BY_INVITATION2
WITHDRAWN2
Phase mix
NA93
PHASE336
PHASE427
PHASE213
PHASE18
EARLY_PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.